Complement Therapeutics

About:

Complement Therapeutics operates as a preclinical stage company.

Website: https://complementtx.com/

Top Investors: Cambridge Innovation Capital, Forbion Capital Partners, Gimv, BioGeneration Ventures, Seroba Life Sciences

Description:

Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their complement-activation profile with the potential to enable both patient selection and serving as an efficacy biomarker in future clinical studies.